Headache and combination estrogen-progestin oral contraceptives: Integrating evidence, guidelines, and clinical practice

Elizabeth W. Loder, Dawn C. Buse, Joan R. Golub

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Primary headache disorders such as migraine affect almost a third of women during their childbearing years, when decisions about contraception must be made. Headache is also a commonly reported adverse event in clinical trials of oral contraceptives (OCs). Health care practitioners will frequently be called upon to give advice about the use of OCs to women with headache. This article applies current evidence, guidelines, and recommendations about headache and OC use to treatment decisions in four clinical scenarios: initiating OC use in a woman who has migraine without aura, continuing OC use in a woman who experiences worsening of migraine and the development of aura after initiating OCs, initiating OC use in a woman with tension-type headache (TTH) and a family history of migraine, and use of an extended duration OC regimen to minimize migraine triggered by estrogen withdrawal. The authors' recommendations regarding OC use in various primary headache disorders are summarized.

Original languageEnglish (US)
Pages (from-to)224-231
Number of pages8
JournalHeadache
Volume45
Issue number3
DOIs
StatePublished - Mar 2005
Externally publishedYes

Fingerprint

Progestins
Oral Contraceptives
Practice Guidelines
Headache
Estrogens
Migraine Disorders
Primary Headache Disorders
Migraine without Aura
Tension-Type Headache
Contraception
Epilepsy
Clinical Trials
Guidelines
Delivery of Health Care

Keywords

  • Guidelines
  • Migraine
  • Oral contraceptives
  • Recommendations
  • Review

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Headache and combination estrogen-progestin oral contraceptives : Integrating evidence, guidelines, and clinical practice. / Loder, Elizabeth W.; Buse, Dawn C.; Golub, Joan R.

In: Headache, Vol. 45, No. 3, 03.2005, p. 224-231.

Research output: Contribution to journalArticle

Loder, Elizabeth W. ; Buse, Dawn C. ; Golub, Joan R. / Headache and combination estrogen-progestin oral contraceptives : Integrating evidence, guidelines, and clinical practice. In: Headache. 2005 ; Vol. 45, No. 3. pp. 224-231.
@article{450e5b38152349df8497212d2937dd38,
title = "Headache and combination estrogen-progestin oral contraceptives: Integrating evidence, guidelines, and clinical practice",
abstract = "Primary headache disorders such as migraine affect almost a third of women during their childbearing years, when decisions about contraception must be made. Headache is also a commonly reported adverse event in clinical trials of oral contraceptives (OCs). Health care practitioners will frequently be called upon to give advice about the use of OCs to women with headache. This article applies current evidence, guidelines, and recommendations about headache and OC use to treatment decisions in four clinical scenarios: initiating OC use in a woman who has migraine without aura, continuing OC use in a woman who experiences worsening of migraine and the development of aura after initiating OCs, initiating OC use in a woman with tension-type headache (TTH) and a family history of migraine, and use of an extended duration OC regimen to minimize migraine triggered by estrogen withdrawal. The authors' recommendations regarding OC use in various primary headache disorders are summarized.",
keywords = "Guidelines, Migraine, Oral contraceptives, Recommendations, Review",
author = "Loder, {Elizabeth W.} and Buse, {Dawn C.} and Golub, {Joan R.}",
year = "2005",
month = "3",
doi = "10.1111/j.1526-4610.2005.05049.x",
language = "English (US)",
volume = "45",
pages = "224--231",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Headache and combination estrogen-progestin oral contraceptives

T2 - Integrating evidence, guidelines, and clinical practice

AU - Loder, Elizabeth W.

AU - Buse, Dawn C.

AU - Golub, Joan R.

PY - 2005/3

Y1 - 2005/3

N2 - Primary headache disorders such as migraine affect almost a third of women during their childbearing years, when decisions about contraception must be made. Headache is also a commonly reported adverse event in clinical trials of oral contraceptives (OCs). Health care practitioners will frequently be called upon to give advice about the use of OCs to women with headache. This article applies current evidence, guidelines, and recommendations about headache and OC use to treatment decisions in four clinical scenarios: initiating OC use in a woman who has migraine without aura, continuing OC use in a woman who experiences worsening of migraine and the development of aura after initiating OCs, initiating OC use in a woman with tension-type headache (TTH) and a family history of migraine, and use of an extended duration OC regimen to minimize migraine triggered by estrogen withdrawal. The authors' recommendations regarding OC use in various primary headache disorders are summarized.

AB - Primary headache disorders such as migraine affect almost a third of women during their childbearing years, when decisions about contraception must be made. Headache is also a commonly reported adverse event in clinical trials of oral contraceptives (OCs). Health care practitioners will frequently be called upon to give advice about the use of OCs to women with headache. This article applies current evidence, guidelines, and recommendations about headache and OC use to treatment decisions in four clinical scenarios: initiating OC use in a woman who has migraine without aura, continuing OC use in a woman who experiences worsening of migraine and the development of aura after initiating OCs, initiating OC use in a woman with tension-type headache (TTH) and a family history of migraine, and use of an extended duration OC regimen to minimize migraine triggered by estrogen withdrawal. The authors' recommendations regarding OC use in various primary headache disorders are summarized.

KW - Guidelines

KW - Migraine

KW - Oral contraceptives

KW - Recommendations

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=15344339212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15344339212&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2005.05049.x

DO - 10.1111/j.1526-4610.2005.05049.x

M3 - Article

C2 - 15836597

AN - SCOPUS:15344339212

VL - 45

SP - 224

EP - 231

JO - Headache

JF - Headache

SN - 0017-8748

IS - 3

ER -